TrovaGene Inc. (TROV) Soars 8.33% on April 05

TrovaGene Inc. (TROV) Soars 8.33% on April 05

TrovaGene Inc. (TROV) had a good day on the market for Friday April 05 as shares jumped 8.33% to close at $3.90. About 7.71 million shares traded hands on 26,042 trades for the day, compared with an average daily volume of n/a shares out of a total float of 4.02 million. After opening the trading day at $4.78, shares of TrovaGene Inc. stayed within a range of $4.82 to $3.90.

With today’s gains, TrovaGene Inc. now has a market cap of $15.66 million. Shares of TrovaGene Inc. have been trading within a range of $28.44 and $2.54 over the last year, and it had a 50-day SMA of $n/a and a 200-day SMA of $n/a.

TrovaGene Inc is a US-based life science company which focuses on the development and commercialization of a proprietary molecular genetic detection technology for use in pharmaceutical development, clinical research and medical testing across a variety of clinical disciplines, including oncology and virology. Its primary focus is to utilize its technology in measuring circulating tumor DNA (deoxyribonucleic acid) in urine and blood with its proprietary platforms and research. The company has developed Trover liquid biopsy tests for use by physicians, third-party clinical laboratories, and pharmaceutical companies.

TrovaGene Inc. is based out of San Diego, CA and has some 17 employees. Its CEO is Thomas H. Adams.

Scroll Up
error: Content is protected !!